Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels: A Case Series.

作者信息

Cellini Lorenzo, De Donatis Domenico, Mercolini Laura, Panariello Fabio, De Ronchi Diana, Serretti Alessandro, Conca Andreas, Gaspari Davide, Giupponi Giancarlo, Zernig Gerald, Florio Vincenzo

出版信息

J Clin Psychopharmacol. 2021;41(6):694-696. doi: 10.1097/JCP.0000000000001461.

DOI:10.1097/JCP.0000000000001461

PMID:34735103

Abstract

摘要

相似文献

Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels: A Case Series.

J Clin Psychopharmacol. 2021;41(6):694-696. doi: 10.1097/JCP.0000000000001461.

A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic.一项关于患者从每月一次棕榈酸帕利哌酮（PP1M）换用每三个月一次棕榈酸帕利哌酮（PP3M）长效注射用抗精神病药物时的体验的定性研究。

Schizophr Res. 2019 Feb;204:443-444. doi: 10.1016/j.schres.2018.09.012. Epub 2018 Sep 18.

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.帕利哌酮棕榈酸酯3个月剂型在精神分裂症患者中的药代动力学、安全性及耐受性：一项1期单剂量随机开放标签研究。

J Clin Pharmacol. 2016 Mar;56(3):330-9. doi: 10.1002/jcph.597. Epub 2015 Oct 5.

Long-acting injectable antipsychotics: choosing the right dose.长效注射用抗精神病药物：选择合适剂量

J Psychiatry Neurosci. 2020 Jul 1;45(4):298. doi: 10.1503/jpn.200015.

Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).棕榈酸帕利哌酮长效注射制剂在精神分裂症谱系障碍中的应用：首发精神病干预计划（CRUPEP）的回顾性队列研究。

Int J Neuropsychopharmacol. 2021 Sep 21;24(9):694-702. doi: 10.1093/ijnp/pyab021.

Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability.帕利哌酮长效血药浓度监测及临床稳定性评估新方法

Pharmacopsychiatry. 2017 Jul;50(4):145-151. doi: 10.1055/s-0037-1601396. Epub 2017 Mar 9.

Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.长效注射用帕利哌酮棕榈酸酯：疗效与安全性综述

Psychopharmacol Bull. 2017 May 15;47(2):42-52.

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.氯氮平联合棕榈酸帕利哌酮治疗难治性精神分裂症及其他精神病性障碍：一项为期 6 个月的回顾性镜像研究。

Eur Psychiatry. 2020 Jul 16;63(1):e71. doi: 10.1192/j.eurpsy.2020.72.

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.棕榈酸帕利哌酮单月制剂对精神分裂症患者复发预防的影响：一项为期一年、开放性研究的事后分析，按药物依从性分层。

J Psychopharmacol. 2018 Jun;32(6):691-701. doi: 10.1177/0269881118772449. Epub 2018 May 16.

Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.在社区环境中接受棕榈酸帕利哌酮治疗的精神分裂症患者的康复结果：患者和医疗服务提供者对康复的看法

J Med Econ. 2016;19(5):469-76. doi: 10.3111/13696998.2015.1131989. Epub 2015 Dec 31.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验